Walking On Eggshells

Tunick, Britt Erica; O'Leary, Christopher
April 2004
Investment Dealers' Digest;4/5/2004, Vol. 70 Issue 14, p32
Trade Publication
Explores the performance of the U.S. capital markets. Initial public offerings; Qualities of companies that have been making their way to market; Investors' appetite for risk; Performance of the high-yield bond market; Impact of the merger and acquisition activity; Increase in deals tailored to make issuer financing more flexible.


Related Articles

  • Investors Get Window To Prep For Ipos, Analysts Say. Young, Vicki M. // WWD: Women's Wear Daily;8/5/2008, Vol. 196 Issue 26, p14 

    The article focuses on the prospects of the initial public offering (IPO) market for the consumer sector in the U.S. Chris Sciortino, a director of the investment banking unit of Robert W. Baird & Co. Inc., noted prospective buyers are being conservative because the consumer still seems to be...

  • Asset Manager M&A Expected to Remain Robust.  // Money Management Executive;8/11/2008, Vol. 16 Issue 32, p4 

    The article focuses on the report by Jefferies Putnam Lovell regarding enthusiasm of Investment firms to continue raise capital through mergers and acquisitions (M&A). The investment banking firm believes the rise of M&A, is due to the focus on smaller transactions, more alternatives and no...

  • LBO-Backed IPOs Treading Water. O'Connor, Colleen Marie // Investment Dealers' Digest;5/16/2005, Vol. 71 Issue 19, p7 

    Reports on key controversies pertaining to leverage buyout-backed initial public offerings in the U.S. Irritation of investors over the greediness of buyout owners; Trends in corporate mergers and acquisitions; Deals and agreements between companies and investors.

  • THE COST OF OWNERSHIP. Koury, Fred // Smart Business St. Louis;Jul2012, Vol. 5 Issue 7, p4 

    The author argues that a Chief Executive Officer's role is to ensure a company's growth by creating an environment of long-term relationships and to take responsibility for the investors, employees, vendors and the economy as a whole. He mentions initial public offering (IPO), mergers,...

  • Reverse Mergers and Takeovers. Banwo, Adedayo // International Law News;Fall2011, Vol. 40 Issue 4, p21 

    This article discusses several issues in the context of reserve mergers or reverse takeovers (RTOs). It has been stated that number of RTOs has significantly increased in recent years as wealthy investors increased investments in emerging markets. It has been stated that RTOs is considered as a...

  • Merging Activity as a Rational Explanation for the Long-Run Underperformance of IPO. Sentis, Patrick // Multinational Finance Journal;Mar-Jun2009, Vol. 13 Issue 1/2, p201 

    The phenomena of IPO underpricing and underperformance are examined in the same rational model. In this model, underpricing is caused by the presence of uninformed investors. Low-type firms carry out an IPO under the same conditions as high-type firms. Instead of investing by themselves, the...

  • Hoovers IPO report confirms decline in new offerings.  // Fairfield County Business Journal;7/11/2005, Vol. 44 Issue 28, p36 

    Reports on the decline in the number of U.S. initial public offerings (IPO) for the second quarter of 2005. Amount raised by the 46 companies which went public in the second quarter of the year; Consideration of IPO hopefuls for a public offering or potential merger and acquisition activity, as...

  • Blue Harbour seeks $330M to work with. Soule, Alexander // Fairfield County Business Journal;3/24/2008, Vol. 47 Issue 12, p20 

    The article reports on the plans of Clifton Robbins, the founder of the Blue Harbour Group LP which is based in Greenwich, Connecticut to raise at least $330 million in an initial public offering (IPO) of stock to use the money to acquire an operating company. Under the blank check ruling, IPOs...

  • Earlier stage biotechs attract partners. Ratner, Mark // Nature Biotechnology;May2005, Vol. 23 Issue 5, p509 

    The article reports on certain favorable financing alternatives available to most biotech companies and their investors regarding going public. A spate of recent acquisitions and a continuation of early-stage deal making signify that there are still appealing ways for many companies to sustain...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics